CLINICAL_TRIALS
trial_result
· 2020-12-14
Clinical Trial Update: Safety and Efficacy of Nerinetide (NA-1) in Subjects Undergoing Endovascular Thrombectomy for Stroke [Phase 3]
Summary
Phase 3 study of Nerinetide (NA-1) in acute stroke patients undergoing endovascular thrombectomy has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: NoNO Inc. | Conditions: Stroke, Acute | Phase 3 | Status: COMPLETED | Results posted: 2020-12-14